Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Perampanel in Young Children with Epilepsy

Perampanel as Adjunctive Therapy in Children 1 mo - 2 years with Epilepsy

Description:

For complete study information, please view the study on clinicaltrials.gov

Study Status:

Closed

Full IRB Study Title:

An Open-Label Study With an Extension Phase to Evaluate the Pharmacokinetics of Perampanel (E2007) Oral Suspension When Given as an Adjunctive Therapy in Subjects From 1 Month to Less Than 24 Months (<2 years) of Age With Epilepsy

IRB Study ID:

1057929

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

Lead Investigator

Michael Kohrman, MD

Director, Pediatric Neurology; Pediatric Neurologist
Pediatric Epilepsy ProgramTuberous Sclerosis ClinicNeuroDevelopmental Science Center

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...